- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02843750
Study of Inspiratory Muscle Training for Patients Undergoing Esophageal Surgery
December 14, 2016 updated by: Roberto P. Benzo, Mayo Clinic
A Pilot Study of Inspiratory Muscle Training for Patients Undergoing Esophageal Surgery
To obtain definitive evidence for the effectiveness of a short preoperative inspiratory muscle training (IMT) protocol on the morbidity and recovery from an esophageal surgical resection.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic in Rochester
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 99 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- All patients diagnosed with esophageal cancer and scheduled for esophageal resection at the Mayo Clinic Rochester with gastric conduit reconstruction -Cognitively capable to understand and perform a preoperative program
- Able to follow the intervention program for at least 2 weeks before surgery (surgery is usually scheduled 4 to 12 weeks after radiation)
- Willing to sign the informed consent form
Exclusion Criteria:
- Unable to communicate in the English language
- Participating in a conflicting trial concerning esophageal resection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Inspiratory Muscle Training-Rehabilitation
Patients will start the IMT-R, following their consent and within 2 weeks of their scheduled surgery: 10 sessions lasting about 90 minutes.
Participants who completed their initial IMT greater than 2 weeks prior to surgery will have an additional visit prior to surgery.
Participants will receive a Participant Manual demonstrating and explaining the rehabilitation process.
Participants will also receive a log for recording their efforts and notes.
A DVD of the rehabilitation is available to the participant.
Participants will complete questionnaires at baseline and 3 months.
|
The training will include the following components:
Patient quality of life will be measured using patient-reported outcomes measurement information system (PROMIS) global items.
Patients will also complete the Chronic Respiratory Questionnaire (CRQ) and the Medical Research Council Dyspnea Scale (MCR).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative Pneumonia
Time Frame: 3 months
|
To prospectively determine the effect of a customized preoperative inspiratory muscle training (IMT) and brief pulmonary rehabilitation program on the incidence of postoperative pneumonia in patients that undergo an esophageal surgical resection.
The investigators will consider the following as pneumonia: new infiltrate + either fever (>38.5 C) and white cell count >11,000 or fever and purulent secretions.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative Pulmonary Complications
Time Frame: 3 months
|
To prospectively determine the effect of a customized preoperative inspiratory muscle training (IMT) and brief pulmonary rehabilitation program on the incidence of postoperative pulmonary complications in patients that undergo an esophageal surgical resection.The investigators will consider the following events as post-operative pulmonary complications: severe atelectasis (requiring bronchoscopy) and respiratory failure (intubation or prolonged mechanical ventilation (>24hours).
|
3 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length of Hospital Stay
Time Frame: 3 months
|
Length of hospital stay will be measured by participant monitoring while hospitalized until hospital discharge.
|
3 months
|
|
Quality of Life
Time Frame: Baseline to 3 months
|
Quality of life will be assessed at baseline and at 3 months after hospital discharge by participant completion of the PROMIS Global 10.
|
Baseline to 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2016
Primary Completion (ANTICIPATED)
June 1, 2017
Study Completion (ANTICIPATED)
June 1, 2017
Study Registration Dates
First Submitted
July 11, 2016
First Submitted That Met QC Criteria
July 21, 2016
First Posted (ESTIMATE)
July 26, 2016
Study Record Updates
Last Update Posted (ESTIMATE)
December 15, 2016
Last Update Submitted That Met QC Criteria
December 14, 2016
Last Verified
December 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15-009190
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Esophageal Cancer
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityWithdrawnStage IIB Esophageal Cancer AJCC v7 | Stage III Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IIIC Esophageal Cancer AJCC v7
-
National Cancer Institute (NCI)NRG OncologyCompletedEsophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Stage IIA Esophageal Cancer AJCC v7 | Stage IIB Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IB Esophageal Cancer AJCC v7United States
-
Essen BiotechRecruitingStomach Cancer | Esophageal Cancer | Stomach Cancer, Adenocarcinoma | Stomach Cancer Recurrent | Esophageal Cancer Metastatic to Bone | Esophageal Cancer Metastatic to Lung | Esophageal Cancer Metastatic to LiverChina
-
AIO-Studien-gGmbHBristol-Myers SquibbCompletedEsophageal Cancer | Gastrooesophageal Cancer | Oesophageal Cancer | GastroEsophageal Cancer | Esophageal Cancers NOS | Oesophageal Cancer Metastatic | Esophageal Cancer Metastatic | Oesophageal Cancer NosGermany
-
University of Wisconsin, MadisonCompletedResectable Esophageal Cancer | GastroEsophageal CancerUnited States
-
Tianjin Medical University Cancer Institute and...Sun Yat-sen University; Cancer Institute and Hospital, Chinese Academy of Medical... and other collaboratorsNot yet recruitingStage III Esophageal Cancer | Stage II Esophageal Cancer
-
Tianjin Medical University Cancer Institute and...UnknownStage III Esophageal Cancer | Stage II Esophageal CancerChina
-
Cancer Institute and Hospital, Chinese Academy...Tianjin Medical University Cancer Institute and Hospital; Sichuan Cancer Hospital...UnknownEsophageal Neoplasm | Esophageal Cancer TNM Staging Primary Tumor (T) T3 | Esophageal Cancer TNM Staging Primary Tumor (T) T2 | Esophageal Cancer TNM Staging Regional Lymph Nodes (N) N0 | Esophageal Cancer TNM Staging Distal Metastasis (M) M0China
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedGastroesophageal Junction Adenocarcinoma | Stage IIA Esophageal Cancer AJCC v7 | Stage IIB Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IIIC Esophageal Cancer AJCC v7 | Malignant Neoplasm of the Cervical Esophagus | Malignant Neoplasm...United States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UMC UtrechtCompletedEsophageal Cancer, Stage II | Esophageal Cancer Stage IIINetherlands
Clinical Trials on Inspiratory Muscle Training-Rehabilitation
-
Universidade do Estado do ParáNot yet recruitingPulmonary Disease, Chronic ObstructiveBrazil
-
Universidad Complutense de MadridInstituto de Salud Carlos III; Hospital Universitario 12 de Octubre; European... and other collaboratorsCompletedIschemic Heart DiseaseSpain
-
Centro de Reabilitacao do NorteAveiro UniversityRecruitingGuillain-Barré SyndromePortugal
-
National Taiwan University HospitalCompleted
-
Chang Gung Memorial HospitalCompleted
-
University of Santa Cruz do SulCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
Istanbul Medipol University HospitalCompletedLung Transplantation | Inspiratory Muscle Training
-
Istanbul Medipol University HospitalCompletedLung Transplant | Inspiratory Muscle Training
-
Qassim UniversityCairo University; Prince Sattam Bin Abdulaziz UniversityCompletedBurns | Children | Respiratory Function ImpairedSaudi Arabia
-
Qassim UniversityCairo UniversityCompleted